Stay updated with breaking news from Xwpharma Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The narcolepsy drugs market size is forecasted to increase by USD 1.60 billion from 2021 to 2026, at a CAGR of 9.1%, according to the recent...
/PRNewswire/ -- The latest market analysis report titled Narcolepsy Drugs Market by Type and Geography - Forecast and Analysis 2022-2026 has been added to...
ADELAIDE, AUS, Oct 19, 2021 - (ACN Newswire) - Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
Business Scoop provides news and views on Business and Markets from New Zealand